Pembroke Management LTD Has $21.02 Million Stock Position in Stevanato Group S.p.A. (NYSE:STVN)

Pembroke Management LTD boosted its position in Stevanato Group S.p.A. (NYSE:STVN) by 143.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,051,140 shares of the company’s stock after acquiring an additional 619,747 shares during the period. Stevanato Group accounts for 2.7% of Pembroke Management LTD’s portfolio, making the stock its 15th largest position. Pembroke Management LTD’s holdings in Stevanato Group were worth $21,023,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. boosted its stake in shares of Stevanato Group by 54.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock valued at $84,000 after purchasing an additional 1,086 shares during the last quarter. nVerses Capital LLC bought a new position in Stevanato Group in the third quarter valued at approximately $84,000. Hilltop National Bank boosted its stake in Stevanato Group by 34.3% in the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after acquiring an additional 1,122 shares during the last quarter. Oppenheimer Asset Management Inc. acquired a new stake in Stevanato Group during the 1st quarter worth $241,000. Finally, Harbor Capital Advisors Inc. raised its position in shares of Stevanato Group by 109.1% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock valued at $163,000 after acquiring an additional 4,626 shares during the last quarter.

Stevanato Group Price Performance

STVN opened at €19.59 ($21.29) on Friday. The firm’s fifty day moving average is €19.57 and its two-hundred day moving average is €20.45. Stevanato Group S.p.A. has a twelve month low of €16.56 ($18.00) and a twelve month high of €34.73 ($37.75). The company has a current ratio of 1.74, a quick ratio of 1.13 and a debt-to-equity ratio of 0.19.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Tuesday, August 6th. The company reported €0.09 ($0.10) EPS for the quarter, missing the consensus estimate of €0.10 ($0.11) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The business had revenue of €259.60 million for the quarter, compared to analyst estimates of €254.92 million. During the same period in the previous year, the business posted $0.15 EPS. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. Equities research analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Analyst Ratings Changes

STVN has been the topic of several recent research reports. Morgan Stanley reduced their price target on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, July 15th. Citigroup reduced their target price on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.